TECHVISION
832876
JING JU LIN
873305
Jing-Jin Electric Technologies
688280
4
Unionman Technology Co.,Ltd.
688609
5
Kingchem
301509
CN Stock MarketDetailed Quotes
688221 Frontier Biotechnologies Inc.
- 8.62
- +0.04+0.47%
Market Closed May 6 15:00 CST
3.23BMarket Cap-17.00P/E (TTM)
8.79High8.58Low31.33KlotVolume8.62Open8.58Pre Close27.21MTurnover0.84%Turnover RatioLossP/E (Static)374.58MShares10.7152wk High2.94P/B3.23BFloat Cap4.4852wk Low10.30Limit Up374.58MShs Float35.53Historical High6.86Limit Down2.45%Amplitude4.48Historical Low--Dividend TTM8.68Avg Price19.12KlotAsk--Div YieldTTM100Lot Size11.65KlotBid
Frontier Biotechnologies Inc. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 14.93%28.33M | 13.32%129.47M | 26.90%91.64M | 20.30%51.06M | 106.93%24.65M | 34.82%114.25M | 25.25%72.22M | 62.20%42.44M | 110.06%11.91M | 109.22%84.74M |
| Operating revenue | 14.93%28.33M | 13.32%129.47M | 26.90%91.64M | 20.30%51.06M | 106.93%24.65M | 34.82%114.25M | 25.25%72.22M | 62.20%42.44M | 110.06%11.91M | 109.22%84.74M |
| Total operating cost | -13.60%74.91M | -12.88%405.69M | -15.69%282.02M | -18.77%185.2M | -7.57%86.7M | -3.24%465.67M | 5.25%334.52M | 31.53%227.98M | 27.66%93.8M | 34.15%481.28M |
| Operating cost | 12.63%19.13M | 5.45%85.55M | 5.24%60.95M | -3.71%35.38M | 33.00%16.99M | 17.61%81.12M | 11.45%57.92M | 39.04%36.74M | 60.14%12.77M | 30.56%68.97M |
| Operating tax surcharges | -22.72%775.15K | 45.05%4.6M | 62.86%3.63M | 56.40%2.32M | 34.67%1M | 6.20%3.17M | 3.06%2.23M | 6.73%1.48M | 41.51%744.86K | 50.83%2.98M |
| Operating expense | 26.46%21.24M | 33.30%86.34M | 11.55%47.92M | 20.36%34.12M | 32.86%16.8M | 19.13%64.77M | 4.87%42.96M | 5.90%28.35M | -4.35%12.64M | -9.66%54.37M |
| Administration expense | -3.45%17.14M | -10.48%84.82M | -20.09%52.39M | -19.42%36.45M | -19.49%17.76M | 17.46%94.75M | 8.09%65.56M | 22.22%45.24M | 32.31%22.05M | 5.27%80.67M |
| Financial expense | -324.16%-187.82K | -5.96%7.18M | 75.65%7.78M | -0.49%4.22M | -93.24%83.79K | 17,033.36%7.63M | 550.14%4.43M | 530.23%4.24M | 268.11%1.24M | 99.09%-45.07K |
| -Interest expense (Financial expense) | 14.42%2.36M | 23.87%10.27M | 31.62%7.92M | 45.22%5.15M | 32.20%2.07M | 86.39%8.29M | 87.63%6.01M | 76.79%3.55M | 76.27%1.56M | 266.62%4.45M |
| -Interest Income (Financial expense) | -144.35%-2.8M | 28.90%-4.12M | 58.28%-1.8M | 72.90%-969.74K | 53.91%-1.15M | -1.50%-5.79M | 1.95%-4.32M | -2.40%-3.58M | -9.88%-2.49M | 18.45%-5.71M |
| Research and development | -50.68%16.8M | -35.95%137.21M | -32.26%109.34M | -35.05%72.7M | -23.17%34.07M | -21.91%214.23M | -1.02%161.42M | 38.08%111.93M | 23.79%44.35M | 59.39%274.33M |
| Credit Impairment Loss | -550.75%-897.5K | 361.79%253.23K | 14.73%-1.47M | 93.24%-77.11K | -20.58%-137.92K | 102.70%54.84K | -79.14%-1.72M | -1,437.08%-1.14M | -144.93%-114.38K | -81.77%-2.03M |
| Asset Impairment Loss | 69.55%-152.43K | -1,348.72%-46.73M | -15,337.62%-41.14M | -15,831.59%-41.56M | ---500.56K | -752.80%-3.23M | ---266.5K | ---260.84K | ---- | -112.12%-378.22K |
| Other net revenue | ||||||||||
| Fair value change income | -117.18%-206.45K | 107.92%83.51K | 190.77%991.38K | 400.95%849.43K | 416.32%1.2M | -319.99%-1.06M | -42.38%-1.09M | 4.68%-282.25K | -124.97%-379.93K | -135.03%-251.2K |
| Invest income | -86.27%461.62K | 374.63%84.09M | -17.41%11.64M | -8.63%8.02M | -19.93%3.36M | -12.27%17.72M | -9.37%14.09M | -3.36%8.77M | 6.82%4.2M | -45.85%20.2M |
| -Including: Investment income associates | ---2.25M | ---3.04M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | 2,939.27%15.35K | 100.61%18.8K | 106.33%18.8K | 106.13%18.8K | 99.74%-540.77 | -121,828.86%-3.08M | -11,666.27%-296.81K | -12,057.85%-306.68K | -185,621.65%-208.57K | -174.14%-2.52K |
| Other revenue | 24.46%3.22M | 181.69%37.4M | 167.47%27.14M | 8.90%6.68M | -10.95%2.59M | -38.89%13.28M | -46.13%10.15M | -61.17%6.14M | -8.44%2.91M | 102.19%21.73M |
| Operating profit | 20.53%-44.14M | 38.64%-201.09M | 19.98%-193.2M | 7.19%-160.21M | 26.43%-55.54M | 8.27%-327.73M | -6.11%-241.44M | -40.91%-172.62M | -28.11%-75.49M | -33.57%-357.28M |
| Add:Non operating Income | 1,363.37%16.19K | -72.67%22.85K | 94.14%20.5K | 248.78%4.15K | 482.21%1.11K | -95.93%83.6K | -99.49%10.56K | -98.64%1.19K | -99.77%190 | -31.54%2.05M |
| Less:Non operating expense | -99.08%1.58K | -76.29%311.9K | -72.76%283.17K | -45.25%253.92K | -22.79%171.66K | -14.56%1.32M | -2.39%1.04M | -45.04%463.77K | -44.42%222.31K | 98.03%1.54M |
| Total profit | 20.80%-44.12M | 38.78%-201.38M | 20.21%-193.46M | 7.29%-160.46M | 26.42%-55.71M | 7.79%-328.96M | -7.05%-242.47M | -40.42%-173.08M | -27.80%-75.71M | -34.49%-356.76M |
| Net profit | 20.80%-44.12M | 38.78%-201.38M | 20.21%-193.46M | 7.29%-160.46M | 26.42%-55.71M | 7.79%-328.96M | -7.05%-242.47M | -40.42%-173.08M | -27.80%-75.71M | -34.49%-356.76M |
| Net profit from continuing operation | 20.80%-44.12M | 38.78%-201.38M | 20.21%-193.46M | 7.29%-160.46M | 26.42%-55.71M | 7.79%-328.96M | -7.05%-242.47M | -40.42%-173.08M | -27.80%-75.71M | -34.49%-356.76M |
| Net profit of parent company owners | 20.80%-44.12M | 38.78%-201.38M | 20.21%-193.46M | 7.29%-160.46M | 26.42%-55.71M | 7.79%-328.96M | -7.05%-242.47M | -40.42%-173.08M | -27.80%-75.71M | -37.19%-356.76M |
| Earning per share | ||||||||||
| Basic earning per share | 20.00%-0.12 | 38.64%-0.54 | 20.00%-0.52 | 6.52%-0.43 | 25.00%-0.15 | 10.20%-0.88 | -3.17%-0.65 | -35.29%-0.46 | -25.00%-0.2 | -36.11%-0.98 |
| Diluted earning per share | 20.00%-0.12 | 38.64%-0.54 | 20.00%-0.52 | 6.52%-0.43 | 25.00%-0.15 | 10.20%-0.88 | -3.17%-0.65 | -35.29%-0.46 | -25.00%-0.2 | -36.11%-0.98 |
| Other composite income | 9,987.71%21.56K | 164.18%11.92K | 14.79%-9.92K | 150.87%4.07K | 101.72%213.72 | -122.75%-18.57K | -118.60%-11.64K | -128.62%-8K | -152.14%-12.41K | 553.25%81.62K |
| Other composite income of parent company owners | 9,987.71%21.56K | 164.18%11.92K | 14.79%-9.92K | 150.87%4.07K | 101.72%213.72 | -122.75%-18.57K | -118.60%-11.64K | -128.62%-8K | -152.14%-12.41K | 553.25%81.62K |
| Total composite income | 20.83%-44.1M | 38.79%-201.37M | 20.21%-193.47M | 7.30%-160.46M | 26.43%-55.71M | 7.77%-328.98M | -7.08%-242.48M | -40.46%-173.09M | -27.81%-75.72M | -34.45%-356.68M |
| Total composite income of parent company owners | 20.83%-44.1M | 38.79%-201.37M | 20.21%-193.47M | 7.30%-160.46M | 26.43%-55.71M | 7.77%-328.98M | -7.08%-242.48M | -40.46%-173.09M | -27.81%-75.72M | -37.15%-356.68M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.